36 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Cyp24a1tm1Star/Cyp24a1tm1Star Vdrtm1Mbd/Vdrtm1Mbd involves: 129S4/SvJae	normal skeleton phenotype	J:63457
Fgf23tm1Blan/Fgf23tm1Blan Vdrtm1Rge/Vdrtm1Rge involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6	epidermal cyst	J:121006
	normal homeostasis/metabolism phenotype	J:121006
	increased circulating alkaline phosphatase level	J:121006
	increased circulating parathyroid hormone level	J:121006
Il10tm1Cgn/Il10tm1Cgn Vdrtm1Mbd/Vdrtm1Mbd involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6	abnormal CD4-positive, alpha-beta T cell physiology	J:107077
	abnormal cytokine level	J:107077
	abnormal lymph node cell ratio	J:107077
	abnormal splenic cell ratio	J:107077
	abnormal thymus corticomedullary boundary morphology	J:107077
	abnormal thymus involution	J:107077
	absent spleen white pulp	J:107077
	anemia	J:107077
	colitis	J:107077
	decreased lymphocyte cell number	J:107077
	decreased T cell proliferation	J:107077
	enlarged mesenteric lymph nodes	J:107077
	enlarged spleen	J:107077
	increased macrophage cell number	J:107077
	increased neutrophil cell number	J:107077
	increased spleen red pulp amount	J:107077
	increased T cell apoptosis	J:107077
	intestinal inflammation	J:107077
	rectal prolapse	J:107077
	thymus hypoplasia	J:107077
Tg(VDR*L233S,luc)T807Pike/0 Vdrtm1Mbd/Vdrtm1Mbd involves: 129S4/SvJae * C57BL/6	abnormal epiphyseal plate morphology	J:218709
	abnormal skeleton physiology	J:218709
	decreased bone mineral density	J:218709
	decreased bone mineral density of femur	J:218709
	decreased circulating calcium level	J:218709
	decreased circulating phosphate level	J:218709
	increased activity of parathyroid	J:218709
	increased circulating parathyroid hormone level	J:218709
	normal integument phenotype	J:218709
	parathyroid gland hyperplasia	J:218709
	rickets	J:218709
	short tibia	J:218709